HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chien-Hsing Chang Selected Research

milatuzumab

1/2013Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.
4/2012Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas.
9/2007CD74: a new candidate target for the immunotherapy of B-cell neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chien-Hsing Chang Research Topics

Disease

59Neoplasms (Cancer)
10/2020 - 05/2002
14Lymphoma (Lymphomas)
01/2015 - 12/2005
11Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2015 - 09/2007
6Pancreatic Neoplasms (Pancreatic Cancer)
05/2015 - 01/2008
5B-Cell Lymphoma (Lymphoma, B Cell)
10/2013 - 02/2008
5Colonic Neoplasms (Colon Cancer)
12/2012 - 11/2005
5Lower Urinary Tract Symptoms
01/2011 - 01/2008
4Multiple Myeloma
01/2018 - 09/2007
4Convalescence
05/2017 - 08/2011
4Burkitt Lymphoma (Burkitt's Lymphoma)
01/2015 - 12/2005
4Leukemia
01/2014 - 06/2010
4Pain (Aches)
12/2011 - 01/2009
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 06/2010
3Stomach Neoplasms (Stomach Cancer)
01/2016 - 10/2014
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2015 - 10/2013
3Colorectal Neoplasms (Colorectal Cancer)
08/2014 - 11/2005
2Triple Negative Breast Neoplasms
10/2020 - 03/2014
2Hodgkin Disease (Hodgkin's Disease)
01/2018 - 01/2013
2Melanoma (Melanoma, Malignant)
01/2018 - 01/2014
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 06/2010
2Sepsis (Septicemia)
05/2017 - 10/2016
2Breast Neoplasms (Breast Cancer)
01/2016 - 03/2014
2Autoimmune Diseases (Autoimmune Disease)
01/2014 - 10/2013
2Neoplasm Metastasis (Metastasis)
01/2014 - 01/2013
2Carcinoma (Carcinomatosis)
04/2013 - 10/2012
2Thyroid Neoplasms (Thyroid Cancer)
08/2012 - 04/2006
2Glioblastoma (Glioblastoma Multiforme)
07/2012 - 09/2006
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2012 - 06/2010
2Hematologic Neoplasms (Hematological Malignancy)
10/2010 - 05/2002
2Colic (Abdominal Cramps)
01/2009 - 01/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Body Weight (Weight, Body)
01/2018
1Adenocarcinoma
02/2015
1Disease Progression
02/2015
1Bites and Stings (Sting)
03/2014

Drug/Important Bio-Agent (IBA)

19HaptensIBA
08/2014 - 09/2003
19Peptides (Polypeptides)IBA
10/2012 - 05/2002
15AntibodiesIBA
01/2014 - 05/2002
13Immunoglobulin G (IgG)IBA
01/2018 - 10/2005
12Carcinoembryonic AntigenIBA
08/2012 - 09/2003
10Monoclonal AntibodiesIBA
02/2015 - 05/2005
9Radioisotopes (Radionuclides)IBA
10/2012 - 05/2002
8Proteins (Proteins, Gene)FDA Link
01/2016 - 09/2003
7AntigensIBA
03/2014 - 09/2007
6Irinotecan (Camptosar)FDA LinkGeneric
10/2020 - 05/2015
6veltuzumabIBA
04/2012 - 10/2008
5Immunoconjugates (Immunoconjugate)IBA
01/2018 - 05/2015
5HLA-DR Antigens (HLA-DR)IBA
01/2018 - 06/2010
5Bispecific AntibodiesIBA
03/2014 - 05/2002
5AcidsIBA
02/2010 - 09/2003
5Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2009 - 11/2005
5Histamine (Histamine Dihydrochloride)FDA Link
12/2009 - 11/2005
4DNA (Deoxyribonucleic Acid)IBA
10/2020 - 07/2012
4sacituzumab govitecanIBA
10/2020 - 05/2015
4epratuzumabIBA
01/2015 - 10/2010
4Analgesics (Analgesic Drugs)IBA
12/2011 - 01/2008
3Biomarkers (Surrogate Marker)IBA
10/2020 - 08/2012
3Pharmaceutical PreparationsIBA
01/2018 - 05/2005
3EpitopesIBA
02/2015 - 12/2009
3milatuzumabIBA
01/2013 - 09/2007
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2012 - 10/2006
3Humanized Monoclonal AntibodiesIBA
10/2010 - 05/2005
3Ribonucleases (Ribonuclease)IBA
08/2010 - 12/2005
3Immunotoxins (Immunotoxin)IBA
08/2010 - 05/2005
3Rituximab (Mabthera)FDA Link
06/2010 - 05/2004
2IMMU-114IBA
01/2018 - 06/2010
2clivatuzumabIBA
02/2015 - 12/2009
2MucinsIBA
02/2015 - 12/2009
2CytokinesIBA
10/2014 - 02/2009
2DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
08/2014 - 04/2010
2ranpirnase (Pannon)IBA
03/2014 - 08/2010
2Antiviral Agents (Antivirals)IBA
01/2013 - 10/2009
2Therapeutic UsesIBA
12/2012 - 12/2009
2IsotopesIBA
06/2012 - 09/2007
2Pentetic Acid (DTPA)FDA LinkGeneric
02/2010 - 02/2006
2Inosine Monophosphate (IMP)IBA
06/2009 - 05/2004
2Immunoglobulin Fab FragmentsIBA
05/2006 - 10/2005
1C 39 (C39)IBA
10/2020
17-ethyl-10-hydroxycamptothecin beta-glucuronideIBA
01/2018
1labetuzumab govitecanIBA
01/2018
1Histocompatibility Antigens Class IIIBA
01/2018
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1CaspasesIBA
05/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2015
1Small Interfering RNA (siRNA)IBA
02/2015
1anti-IgMIBA
01/2015
1InterferonsIBA
10/2014
1Biological ProductsIBA
03/2014

Therapy/Procedure

27Therapeutics
01/2018 - 05/2002
12Radioimmunotherapy
08/2014 - 11/2005
5Immunotherapy
10/2017 - 09/2007
3Stents
06/2009 - 01/2009
2Decompression
05/2017 - 10/2016
2Radiotherapy
04/2013 - 09/2006
2Length of Stay
12/2011 - 08/2011
2Lithotripsy (Extracorporeal Shockwave Lithotripsy)
03/2011 - 01/2009
1Percutaneous Nephrolithotomy
05/2017
1Contraindications
10/2016